Survival outcomes of patients with stage III melanoma treated with adjuvant immunotherapy, with a focus on immune-related adverse events leading to delays in treatment.

Authors: Kevin Zablonski, Jarred Boone, Seunghee P Margevicius, Natalie Chakraborty, Pingfu Fu, Hailey Seibert, Maira Bhatty, Matthew M. Mirsky, Debora S. Bruno, Ankit Mangla, Richard Hoehn, Luke Daniel Rothermel, Iris Yeong- Fung Sheng

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21570

Source: Full article

---

Abstract

e21570